|
Disease Type
|
Phase / Type
|
Title
|
Physician
|
Contact / Phone
|
Protocol Number
|
 Central Nervous System (CNS)
|
|
Leukemia
|
|
Lymphoma
|
|
Melanoma
|
|
Neuroblastoma
|
 Solid Tumors (non CNS)
|
|
|
I
|
A Phase I Study to Evaluate the Safety and Pharmacokinetics of Panitumumab in Children with Solid Tumors
|
Hughes, Dennis, M.D., Ph.D.
|
Philip, Ann
(713) 792-6547
|
2007-0615
|
|
|
I
|
A Phase 1 Study of ADI PEG 20 in Pediatric Subjects Who are Argninosuccinate Synthetase (ASS) Deficient and Have Failed Prior Systemic Therapy
|
Herzog, Cynthia E., M.D.
|
Philip, Ann
(713) 792-6547
|
2010-0555
|
|
Other Divisions' Protocols
|
|
|
I
|
A Phase I Study of Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic Fluorouracil, Leucovorin and Bevacizumab With or Without Cetuximab by K-RAS Mutational Status and Liver Function for Patients with Advanced Cancers Metastatic to the Liver.
|
Tsimberidou, Apostolia Maria, M.D., Ph.D.
|
Herzog, Cynthia E., M.D.
(713) 745-0157
|
2009-0023
|
|
|
I
|
A Phase I Trial of Doxil, Bevacizumab and Temsirolimus
|
Karp, Daniel D.
|
Main Switchboard
(713) 792-6161
|
2008-0384
|
|
|
I
|
A Phase I Trial of Sirolimus and Cetuximab in Patients with Advanced Malignancies
|
Janku, Filip
|
Main Switchboard
(713) 792-6161
|
2009-0226
|
|
|
I
|
A multi-arm Phase I trial of hepatic arterial infusion of irinotecan with 1) systemic bevacizumab and cetuximab 2) systemic bevacizumab and oxaliplatin 3) systemic bevacizumab in patients with advanced solid tumors metastatic to the liver
|
Tsimberidou, Apostolia Maria, M.D., Ph.D.
|
Main Switchboard
(713) 792-6161
|
2009-0410
|
